Kouka Mussab, Koehler Benjamin, Buentzel Jens, Kaftan Holger, Boeger Daniel, Mueller Andreas H, Wittig Andrea, Schultze-Mosgau Stefan, Ernst Thomas, Schlattmann Peter, Guntinas-Lichius Orlando
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany.
Department of Otorhinolaryngology, Suedharzklinikum Nordhausen, 99734 Nordhausen, Germany.
Cancers (Basel). 2022 Jun 7;14(12):2822. doi: 10.3390/cancers14122822.
This population-based study investigated the prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer. All 345 patients (median age: 66 years; 43% female, 49% N+, 31% stage IV) of the Thuringian cancer registries with parotid cancer from 1996 to 2016 were included. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T (T3/T4) became a prognosticator (hazard ratio (HR) = 2.588; CI = 1.329−5.040; p = 0.005) but not LODDS (p > 0.05). When combining T classification with LODDS-PAR, both higher T classification (HR = 2.256; CI = 1.288−3.950; p = 0.004) and the alternative classification with LODDS-PAR (≥median −1.11; HR 2.078; CI = 1.155−3.739; p = 0.015) became independent predictors of worse OS. LODDS-PAR was the only independent prognosticator out of the LN assessment for primary parotid cancer.
这项基于人群的研究调查了腮腺内(PAR)和颈部淋巴结(LN)转移对原发性腮腺癌总生存期(OS)的预后作用。纳入了图林根癌症登记处1996年至2016年期间所有345例腮腺癌患者(中位年龄:66岁;43%为女性,49%有N+,31%为IV期)。根据切除的PAR和颈部LN总数、腮腺内阳性(PAR+)数量、颈部阳性LN数量、LN比值、阳性LN的对数优势(LODDS)以及将PAR纳入作为LODDS - PAR来评估OS。42%的患者进行了PAR评估(其中22%为PAR+)。T和N分类不是OS的独立预测因素。当将T与LODDS而非N相结合时,较高的T(T3/T4)成为一个预后因素(风险比(HR)= 2.588;CI = 1.329 - 5.040;p = 0.005),但LODDS并非如此(p > 0.05)。当将T分类与LODDS - PAR相结合时,较高的T分类(HR = 2.256;CI = 1.288 - 3.950;p = 0.004)以及LODDS - PAR的另一种分类(≥中位数 - 1.11;HR 2.078;CI = 1.155 - 3.739;p = 0.015)都成为OS较差的独立预测因素。对于原发性腮腺癌,LODDS - PAR是LN评估中唯一的独立预后因素。